Beverly Davidson

Chief Scientific Strategy Officer and Director · Children’s Hospital of Philadelphia · company speakers →

Beverly L. Davidson, PhD, serves as the Chief Scientific Strategy Officer and Director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics at the Children’s Hospital of Philadelphia, where she holds the Katherine A. High Chair in Cell and Gene Therapy and is a Professor at the University of Pennsylvania. After earning her PhD from the University of Michigan, Dr. Davidson dedicated her research to the molecular mechanisms of genetic brain diseases, utilizing advanced sequencing and imaging to engineer next-generation gene therapy vectors. Her translational work has led to the founding of Spark Therapeutics, Spirovant Biosciences, and Latus Bio. An elected member of both the National Academy of Medicine and the American Academy of Arts and Sciences, she is a past president of the ASGCT and has received numerous honors, including the Leslie Gehry Brenner Prize and the ASGCT Outstanding Achievement Award.

pharma-biotechhealthcare-services

Is this you? Claim this profile →

No public contact links on file.

Speaking history

American Society of Gene & Cell Therapy Annual Meeting

3 May 2027 Philadelphia, United States “Outstanding Achievement Award Winner”

Topics this speaker covers

pharma-biotechhealthcare-services

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →